sodium magnesium fluorosilicate
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Mar 1, 2013 (NCT02001558)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- CalciumCHELATING AGENT
Calcium chelating agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sodium magnesium fluorosilicate
- sodium magnesium fluorosilicate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02001558 | Phase 4 | Mar 1, 2013 | Sonoma Pharmaceuticals, University of Alabama, Birmingham |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sonoma Pharmaceuticals | For profit | 1 | 0 | 1 | 2013 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 1 | 1 | 2013 |
2 organizations
Page 1 / 1